Reliant Technologies, Inc will be showing off its new Fraxel re:pair™ laser for CO2 skin resurfacing at the American Academy of Dermotology meeting in San Antonio, which is starting today.
The Fraxel re:pair laser system, the result of two years of clinical research, represents a new category in skin rejuvenation: Ablative Fractional Resurfacing (AFRTM) treatment. It is the only device on the market that has received FDA clearance specifically for skin resurfacing with a fractional mode of delivery.
“Ablative fractional skin resurfacing with the Fraxel re:pair laser is the biggest breakthrough for wrinkle removal in the last 10 years,” said Christopher Zachary, FRCP, chair of the Department of Dermatology, University of California at Irvine. “Results approach those we can achieve with a facelift, with very few complications and limited downtime. The Fraxel re:pair system produces significant tissue tightening, wrinkle reduction and textural improvement, both on and off the face.”
The Fraxel re:pair laser is the industry’s only minimally invasive, ablative fractional laser system that delivers a full spectrum of aesthetic treatment from Fractional MicroDermAblation™(FMDA™)treatment to Fractional Deep Dermal Ablation™ (FDDA™) treatment. It is the only ablative resurfacing device capable of being operated by a single clinician, because of its built-in smoke evacuation system, and capable of treating at depths from 300 micrometers (µm) to 1.6 mm into the dermis, all in a single hand piece.